BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29219617)

  • 1. Exploring Multiphoton Microscopy as a Novel Tool to Differentiate Chromophobe Renal Cell Carcinoma From Oncocytoma in Fixed Tissue Sections.
    Jain M; Robinson BD; Wu B; Khani F; Mukherjee S
    Arch Pathol Lab Med; 2018 Mar; 142(3):383-390. PubMed ID: 29219617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.
    Jain S; Roy S; Amin M; Acquafondata M; Yin M; Laframboise W; Bastacky S; Pantanowitz L; Dhir R; Parwani A
    Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
    Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
    Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
    [No Abstract]   [Full Text] [Related]  

  • 4. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
    Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
    Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
    Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
    Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear morphometry as a tool of limited capacity for distinguishing renal oncocytoma from chromophobe carcinoma.
    Okoń K; Sińczak-Kuta A
    Pol J Pathol; 2008; 59(1):9-13. PubMed ID: 18655365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
    Conner JR; Hirsch MS; Jo VY
    Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
    Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.
    Zheng G; Chaux A; Sharma R; Netto G; Caturegli P
    Exp Mol Pathol; 2013 Feb; 94(1):29-32. PubMed ID: 22705098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-needle aspiration biopsy of chromophobe renal cell carcinoma and oncocytoma: comparison of cytomorphologic features.
    Wiatrowska BA; Zakowski MF
    Cancer; 1999 Jun; 87(3):161-7. PubMed ID: 10385448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy for hybrid oncocytic/chromophobe renal cell tumors by exploiting an immunohistochemical and histochemical combined panel.
    Roncati L; Barbolini G; Maiorana A
    Diagnosis (Berl); 2017 Jun; 4(2):109-110. PubMed ID: 29536916
    [No Abstract]   [Full Text] [Related]  

  • 13. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma.
    Alghamdi M; Chen JF; Jungbluth A; Koutzaki S; Palmer MB; Al-Ahmadie HA; Fine SW; Gopalan A; Sarungbam J; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
    Mod Pathol; 2024 May; 37(5):100467. PubMed ID: 38460672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
    Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
    Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
    Lüders C; Kristiansen G
    Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin K (Clone EPR19992) Demonstrates Uniformly Positive Immunoreactivity in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Distal Tubules.
    Iakymenko OA; Delma KS; Jorda M; Kryvenko ON
    Int J Surg Pathol; 2021 Sep; 29(6):600-605. PubMed ID: 33764165
    [No Abstract]   [Full Text] [Related]  

  • 18. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
    Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
    Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma.
    Ng KL; Morais C; Bernard A; Saunders N; Samaratunga H; Gobe G; Wood S
    J Clin Pathol; 2016 Aug; 69(8):661-71. PubMed ID: 26951082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier.
    McGillivray PD; Ueno D; Pooli A; Mendhiratta N; Syed JS; Nguyen KA; Schulam PG; Humphrey PA; Adeniran AJ; Boutros PC; Shuch B
    Eur Urol; 2021 Jan; 79(1):107-111. PubMed ID: 32972793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.